Literature DB >> 15065661

How good is our genome?

Jean-Claude Weill1, Miroslav Radman.   

Abstract

Our genome has evolved to perpetuate itself through the maintenance of the species via an uninterrupted chain of reproductive somas. Accordingly, evolution is not concerned with diseases occurring after the soma's reproductive stage. Following Richard Dawkins, we would like to reassert that we indeed live as disposable somas, slaves of our germline genome, but could soon start rebelling against such slavery. Cancer and its relation to the TP53 gene may offer a paradigmatic example. The observation that the latency period in cancer can be prolonged in mice by increasing the number of TP53 genes in their genome, suggests that sooner or later we will have to address the question of heritable disease avoidance via the manipulation of the human germline.

Entities:  

Mesh:

Year:  2004        PMID: 15065661      PMCID: PMC1693304          DOI: 10.1098/rstb.2003.1369

Source DB:  PubMed          Journal:  Philos Trans R Soc Lond B Biol Sci        ISSN: 0962-8436            Impact factor:   6.237


  15 in total

Review 1.  Genetic pathways that regulate ageing in model organisms.

Authors:  L Guarente; C Kenyon
Journal:  Nature       Date:  2000-11-09       Impact factor: 49.962

Review 2.  The age of cancer.

Authors:  R A DePinho
Journal:  Nature       Date:  2000-11-09       Impact factor: 49.962

Review 3.  Oxidants, oxidative stress and the biology of ageing.

Authors:  T Finkel; N J Holbrook
Journal:  Nature       Date:  2000-11-09       Impact factor: 49.962

4.  Demography. Broken limits to life expectancy.

Authors:  Jim Oeppen; James W Vaupel
Journal:  Science       Date:  2002-05-10       Impact factor: 47.728

5.  Mutation rates in mammalian genomes.

Authors:  Sudhir Kumar; Sankar Subramanian
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-15       Impact factor: 11.205

6.  Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours.

Authors:  L A Donehower; M Harvey; B L Slagle; M J McArthur; C A Montgomery; J S Butel; A Bradley
Journal:  Nature       Date:  1992-03-19       Impact factor: 49.962

7.  p53 mutant mice that display early ageing-associated phenotypes.

Authors:  Stuart D Tyner; Sundaresan Venkatachalam; Jene Choi; Stephen Jones; Nader Ghebranious; Herbert Igelmann; Xiongbin Lu; Gabrielle Soron; Benjamin Cooper; Cory Brayton; Sang Hee Park; Timothy Thompson; Gerard Karsenty; Allan Bradley; Lawrence A Donehower
Journal:  Nature       Date:  2002-01-03       Impact factor: 49.962

8.  "Super p53" mice exhibit enhanced DNA damage response, are tumor resistant and age normally.

Authors:  Isabel García-Cao; Marta García-Cao; Juan Martín-Caballero; Luis M Criado; Peter Klatt; Juana M Flores; Jean-Claude Weill; María A Blasco; Manuel Serrano
Journal:  EMBO J       Date:  2002-11-15       Impact factor: 11.598

Review 9.  Modelling the molecular circuitry of cancer.

Authors:  William C Hahn; Robert A Weinberg
Journal:  Nat Rev Cancer       Date:  2002-05       Impact factor: 60.716

10.  Teratogen-induced eye defects mediated by p53-dependent apoptosis.

Authors:  J A Wubah; M M Ibrahim; X Gao; D Nguyen; M M Pisano; T B Knudsen
Journal:  Curr Biol       Date:  1996-01-01       Impact factor: 10.834

View more
  2 in total

1.  Restoration of an absent G1 arrest and protection from apoptosis in embryonic stem cells after ionizing radiation.

Authors:  Yiling Hong; Peter J Stambrook
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-27       Impact factor: 11.205

2.  Preservation of genomic integrity in mouse embryonic stem cells.

Authors:  Peter J Stambrook; Elisia D Tichy
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.